Comprehensive genomic profiling of Brazilian non‐small cell lung cancer patients ( GBOT 0118/ LACOG0418 )
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comprehensive genomic profiling of
Brazilian
non‐small cell lung cancer patients (
GBOT
0118/
LACOG0418
)
Authors
Keywords
-
Journal
Thoracic Cancer
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-14
DOI
10.1111/1759-7714.13777
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
- (2020) Laura Mezquita et al. Journal of Thoracic Oncology
- Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non–Small Cell Lung Cancer Using a Clinicogenomic Database
- (2019) Gaurav Singal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
- (2019) Kim DeLeonardis et al. Journal of Oncology Practice
- Personalized Medicine, Genomic Profiling and Germline Mutations: Toward More Precise Decisions
- (2019) Ahmad Awada et al. Journal of Oncology Practice
- High prevalence of EGFR mutations in lung adenocarcinomas from Brazilian patients harboring the TP53 p.R337H variant
- (2019) Malu Viter R. Barbosa et al. Clinical Lung Cancer
- Lung cancer in Brazil
- (2018) Luiz Henrique Araujo et al. Jornal Brasileiro de Pneumologia
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma
- (2018) Ferdinandos Skoulidis et al. Cancer Discovery
- Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non–Small-Cell Lung Cancer Harboring ROS1 Rearrangement
- (2017) Sun Min Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- PUB070 Rare Actionable Mutations in a Lung Adenocarcinoma Cohort in Brazil
- (2017) C.G. Ferreira et al. Journal of Thoracic Oncology
- Mutations in TP53 , PIK3CA , PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes
- (2017) Paul A. VanderLaan et al. LUNG CANCER
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors
- (2016) Matteo Canale et al. CLINICAL CANCER RESEARCH
- Dabrafenib plus trametinib in patients with previously treated BRAF V600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
- (2016) David Planchard et al. LANCET ONCOLOGY
- Nondisruptive p53 Mutations Are Associated with Shorter Survival in Patients with Advanced Non-Small Cell Lung Cancer
- (2014) M. A. Molina-Vila et al. CLINICAL CANCER RESEARCH
- Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Biology of Lung Cancer: Clinical Implications
- (2011) Jill E. Larsen et al. CLINICS IN CHEST MEDICINE
- Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
- (2008) Edenir Inêz Palmero et al. CANCER LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started